Smashing "One Size Fits All" Diabetes Care at Last
Sunday, March 13
11:00AM - 12:00PM
110 E 2nd St
The numbers are alarming. More than 29 million people in the U.S. have diabetes, and they want to spend less time managing it. People who treat diabetes want more, better data, and real-time information; payers – including healthcare companies, employers, and, increasingly, all of us – want better outcomes. Enter a new wave of technology that helps personalize solutions and motivate patients individually. This panel brings together patients and key stakeholders who are driving the next generation of technology, drugs, and medical devices, designed to ease the burden of managing chronic conditions like diabetes.
VP Drug Delivery Innovation
Eli Lilly & Company
Having joined Eli Lilly in June 2015, Justin currently serves as Vice President, Drug Delivery Innovation at Lilly’s Cambridge Innovation Center. In his current role, he is tasked to identify and d...Show the rest
Having joined Eli Lilly in June 2015, Justin currently serves as Vice President, Drug Delivery Innovation at Lilly’s Cambridge Innovation Center. In his current role, he is tasked to identify and develop distinct and novel product systems for Lilly’s pipeline. Additionally, he is also leading efforts to establish a maker culture within Lilly and developing new innovation and external partnership models in order to accelerate drug delivery innovation at Lilly. Prior to joining Lilly, Justin spent 8 years at Becton Dickinson (BD) where he served in various roles focused on identifying and commercializing drug delivery systems for the biotech, vaccine, and pharmaceutical industries. During his time at BD he helped commercialize and launch more than 10 drug delivery systems and led efforts in defining the innovation agenda for BD’s $1bn drug delivery portfolio. Prior to BD, just began his career Merck & Company where he spent seven years in roles of increasing responsibility across new product development, product commercialization, and franchise management. During his time at Merck he helped launch 4 new drug products. Justin holds a PhD in Bio-Organic chemistry from Clemson University and spent two years as a research fellow at Harvard Medical School. Justin is the author of more than 25 patents and publications.Hide the rest
The diaTribe Foundation
Kelly Close has over 20 years of experience working at the intersection of marketing, finance, and healthcare. In 2002, she founded Close Concerns, a healthcare information company focused on diabe...Show the rest
Kelly Close has over 20 years of experience working at the intersection of marketing, finance, and healthcare. In 2002, she founded Close Concerns, a healthcare information company focused on diabetes and obesity. Kelly's passion for the field comes from her extensive professional work as well as from her personal experience, having had diabetes for nearly 30 years.
Kelly is Editor-in-Chief of diaTribe, an educational resource for people with diabetes and the Founder and Chair of The diaTribe Foundation, a nonprofit established in 2012 to improve the lives of people with diabetes and pre-diabetes and advocate for action. She has authored over 20 peer-reviewed manuscripts as well as “Targeting A Cure for Type 1 Diabetes: How Long Do We Have to Wait?” a widely-praised book published by the ADA. Kelly is on the editorial board of Clinical Diabetes, a journal focused on diabetes for primary care physicians published quarterly by the ADA.
Prior to Close Concerns, Kelly worked nearly a dozen years on Wall Street in investment banking and medical technology equity research and at McKinsey & Company, where her work centered on pharmaceutical, managed care, and nonprofit organizations.Hide the rest
Manny is an internationally recognized health advocate who has lived with diabetes since 2002. In the past 20 years, he's led dozens of projects and managed a variety of software products. His Elec...Show the rest
Manny is an internationally recognized health advocate who has lived with diabetes since 2002. In the past 20 years, he's led dozens of projects and managed a variety of software products. His Electrical Engineering background (with a masters degree from Cornell University), coupled with his approach to working with people, has helped him build bridges between the technical and business sides.
Between 2007 and 2015, Manny combined his passions at Diabetes Hands Foundation (DHF), a nonprofit he co-founded driven by the belief that no one living with diabetes should feel alone. Under his leadership, DHF became a global leader in diabetes social media, and an influential group in diabetes advocacy with a budget over $1 million.
In May 2015, he joined Livongo Health, as their Senior Vice President - Member Experience. At Livongo he is helping reinvent the way we manage chronic conditions (starting with diabetes) through technology, real-time information and human support to make life easier for people with chronic conditions.
He holds advisory and key volunteer roles with Diabetes Hands Foundation, International Diabetes Federation, American Diabetes Association, Diabetes Coalition of California, and other groups. Born in Venezuela, he came to the US in 2000. He lives in the Bay Area with his wife and artist Andreina Davila, his son Santiago, and their dog Lucas.Hide the rest
mySugr knows diabetes. And it’s the combination of incredibly high technical product quality, beautiful design, and deep understanding of diabetes that makes them unique. They specialize in app-bas...Show the rest
mySugr knows diabetes. And it’s the combination of incredibly high technical product quality, beautiful design, and deep understanding of diabetes that makes them unique. They specialize in app-based, all-around care for people with diabetes – made by people with diabetes. Their apps and services all work together to ease the daily grind, and their motto, "we make diabetes suck less" sums it up nicely.
Scott is an experienced patient advocate. He works with a broad range of stakeholders across the healthcare environment to help them establish effective communication with the patient community. His expertise in the diabetes social media space is recognized worldwide, and he advises organizations within the healthcare, food, and consumer goods industries.
Today he is Communications Lead, USA for mySugr and Patient Pathways Lead at the Delta Project Management consultancy firm. He manages an award-winning blog “Scott's Diabetes” that reaches hundreds of thousands of people annually and co-hosts a weekly radio show with over 30,000 annual listeners.
Scott is also a member of the Children with Diabetes faculty. He is on the Board of Directors for the Diabetes Hands Foundation and the Diabetes Community Advocacy Foundation and is a founding member of Partnering for Diabetes Change. He is interested in how these types of interactions including peer-to-peer support impact patient outcomes.Hide the rest